1. Home
  2. NUAI vs CRBU Comparison

NUAI vs CRBU Comparison

Compare NUAI & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo New Era Energy & Digital Inc.

NUAI

New Era Energy & Digital Inc.

N/A

Current Price

$2.79

Market Cap

190.3M

Sector

Energy

ML Signal

N/A

Logo Caribou Biosciences Inc.

CRBU

Caribou Biosciences Inc.

HOLD

Current Price

$1.64

Market Cap

203.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NUAI
CRBU
Founded
N/A
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Medicinal Chemicals and Botanical Products
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
190.3M
203.9M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
NUAI
CRBU
Price
$2.79
$1.64
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$9.33
AVG Volume (30 Days)
6.0M
963.5K
Earning Date
02-14-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$843,029.00
$9,295,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$3.62
P/E Ratio
N/A
N/A
Revenue Growth
50.89
N/A
52 Week Low
$0.32
$0.66
52 Week High
$7.87
$3.54

Technical Indicators

Market Signals
Indicator
NUAI
CRBU
Relative Strength Index (RSI) 37.27 38.12
Support Level $2.88 $1.63
Resistance Level $4.97 $1.73
Average True Range (ATR) 0.58 0.09
MACD 0.01 0.01
Stochastic Oscillator 5.20 8.62

Price Performance

Historical Comparison
NUAI
CRBU

About NUAI New Era Energy & Digital Inc.

New Era Energy & Digital Inc is engaged into a fully integrated energy supplier delivering next-gen digital infrastructure and power assets. The company provides turnkey solutions to speed up data center deployment and reduce costs. The company focuses on future-proofing infrastructure for hyperscale, enterprise, and edge operators. The company provide integrated energy and digital solutions to support accelerating AI infrastructure deployment and optimize data center investments.

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.

Share on Social Networks: